Dupont Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Dupont Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-603	Closed	-$125K	–	1507
2020 Q2	$125K	Sell	603 -483	-44%	-$112K	﹤0.01%	1228
2020 Q1	$217K	Buy	+1,086	New	+$238K	0.01%	995

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Dupont Capital Management's MTEM Position: Q3 2020 in Review

Dupont Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q3 2020, closing a stake of 603 shares — an estimated $125K sold.

Dupont Capital Management first reported a position in MTEM in Q1 2020 and held it in 2 quarters. The position peaked at $217K in Q1 2020. 103 funds tracked by Wall St. Rank hold MTEM as of Q3 2020.

Dupont Capital Management reported no remaining Molecular Templates, Inc. position as of Q3 2020 after selling out during the quarter.
Dupont Capital Management sold 603 Molecular Templates, Inc. shares in Q3 2020, an estimated $125K.
Dupont Capital Management first reported a position in Molecular Templates, Inc. in Q1 2020 and held it in 2 quarters.
Dupont Capital Management's Molecular Templates, Inc. position peaked at $217K in Q1 2020.
103 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2020.

Based on Dupont Capital Management's 13F filing for Q3 2020, filed 29 Oct 2020.